|
G |
MMP13 |
matrix metallopeptidase 13 |
decreases activity |
EXP |
prinomastat results in decreased activity of MMP13 protein |
CTD |
PMID:17267227 |
|
NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
decreases activity |
EXP |
prinomastat results in decreased activity of MMP2 protein |
CTD |
PMID:17267227 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP3 |
matrix metallopeptidase 3 |
decreases activity |
EXP |
prinomastat results in decreased activity of MMP3 protein |
CTD |
PMID:17267227 |
|
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
|
|
G |
MMP8 |
matrix metallopeptidase 8 |
decreases activity |
EXP |
prinomastat results in decreased activity of MMP8 protein |
CTD |
PMID:17267227 |
|
NCBI chr11:102,711,796...102,724,954
Ensembl chr11:102,711,796...102,727,050
|
|
G |
SLC22A2 |
solute carrier family 22 member 2 |
multiple interactions |
EXP |
prinomastat inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
|
|